Calendar AB Science

Equities

Market Closed - Euronext Paris Other stock markets 11:38:58 2024-04-29 EDT			After market 15:59:59
1.96 ^EUR	+1.24%		1.961	+0.05%

04-04	AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada	MT
04-03	AB Science: reconsideration possible for masitinib in ALS	CF

43dca7396c1.CmlaTcnAP6vad5dX0TPYMWajjSar9T-YUUJxuapc-T4.aQ8QGJipW5-0Tvkxt3ivZgvCtUX-vQ_UDhgfjcgOnHREJiwFrbUS6I8Zrw~c14f4da128cb26f57f94ab4d27131e72

2024-04-29	Q4 2023 Earnings Release
2024-09-29	Q2 2024 Earnings Release
2025-05-05	Q4 2024 Earnings Release (Projected)
2025-10-05	Q2 2025 Earnings Release (Projected)
2026-05-04	Q4 2025 Earnings Release (Projected)
2026-10-04	Q2 2026 Earnings Release (Projected)

2024-03-04 12:30	Business Update Call
2023-11-30 09:00	Business Update Call
2023-09-29 13:49	Q2 2023 Earnings Release
2023-06-30 09:30	Annual General Meeting
2023-05-15	ALS Drug Development Summit
2023-04-28 12:41	Q4 2022 Earnings Release
2023-03-16 13:00	AB8939 Phase 1/2 Study Results Call
2022-09-30 12:39	Interim 2022 Earnings Release
2022-05-23	ALS Drug Development Summit
2022-04-29 12:33	FY 2021 Earnings Release
2022-02-28 12:00	Business Update Call
2021-12-06	International Symposium on ALS/MND
2021-09-30 13:21	Interim 2021 Earnings Release
2021-09-11	American Urological Association Meeting - Study AB12003
2021-07-29 10:00	Alzheimers Association International Conference
2021-06-29	Shareholders Meeting
2021-06-04 09:00	American Society of Clinical Oncology Conference
2021-06-03 12:30	Masitinib Clinical Study Suspension Call
2021-05-25 12:30	Investor Meeting - Key Opinion Leader
2021-04-30 12:45	FY 2020 Earnings Release

Fiscal Period	December	2018	2019	2020	2022	2023
Net sales Million EUR	Released Forecast Spread	1,70	1,57 1,55 1.65%	1,58	0,00	0,93
EBITDA Million EUR	Released Forecast Spread	0,00	0,00 0,00 -	0,00	0,00	-19,1
EBIT Million EUR	Released Forecast Spread	0,00	-17,5 -21,4 18.17%	0,00	0,00	-16,0
Earnings before Tax (EBT)	Released Forecast Spread	0,00	0,00 0,00 -	0,00	0,00	0,00
Net income Million EUR	Released Forecast Spread	0,00	0,00 0,00 -	0,00	-13,6	-19,6
EPS EUR	Released Forecast Spread	0,00	0,00 0,00 -	0,00	-0,29	-0,38
Announcement Date		30/04/19	30/04/20	30/04/21	01/03/23	-

Fiscal Period	December	2019 S1	2019 S2	2020 S1
Net sales Million EUR	Released Forecast Spread	0,79 0,70 13%	0,78 0,80 -2.5%	0,81 0,90 -10.33%
EBIT Million EUR	Released Forecast Spread	-10,6 -14,6 27.54%	-6,90 -10,8 36%
Announcement Date		30/09/19	30/04/20	30/09/20

2024-04-29	YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release
2024-04-29	SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-05-05	HK INNO.N CORPORATION: Q1 2024 Earnings Release (Projected)
2024-05-06	KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-06	KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release
2024-05-06	CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release
2024-05-08 16:05	SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-08	SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-05-09	OSCOTEC INC.: Q1 2024 Earnings Release (Projected)
2024-05-12	MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected)

Today	FRONTIER BIOTECHNOLOGIES INC.: Q1 2024 Earnings Release (Projected)
Today	SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-25	SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-25	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-25 02:00	INDIVIOR PLC: Q1 2024 Earnings Release
2024-04-24	CHANGCHUN BCHT BIOTECHNOLOGY CO.: Q1 2024 Earnings Release (Projected)
2024-04-23	SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)